Le Lézard
Classified in: Health, Business
Subject: DIV

MagMutual Insurance Company Declares Policyholder Dividend for 2024


Marks 25 total years of dividends and more than $400 million in financial rewards

ATLANTA, Jan. 29, 2024 /PRNewswire-PRWeb/ -- MagMutual Insurance Company, one of the nation's leading providers of medical professional liability insurance, announced a 4% dividend return to its PolicyOwners for this year.

"This year marks our 25th year of dividends. I'm proud of that record and pleased we've been able to return so much to the healthcare providers who trust us to protect them," said William S. Kanich, MD, JD, executive chairperson of MagMutual.

With this latest declaration, MagMutual has a record of 25 years of dividends throughout company history. Additionally, they have returned more than $400 million in financial rewards to policyholders since inception and over half of those rewards were paid in the past six years. The insurer also continues to pay for subscriptions to UpToDate®, the premier clinical decision support tool, for policyholders.

"We put our PolicyOwners first, always. Continuously paying dividends reflects our commitment to them," said William S. Kanich, MD, JD, executive chairperson of MagMutual. "This year marks our 25th year of dividends. I'm proud of that record and pleased we've been able to return so much to the healthcare providers who trust us to protect them."

MagMutual is the largest mutual insurer of physicians and the second largest mutual medical professional liability insurer in the country, providing coverage to more than 40,000 physicians and healthcare organizations nationwide.*

"MagMutual's financial strength and growth is unrivaled. With the successful management of our company, we continue to declare dividends and at a higher rate," said Neil Morrell, MagMutual CEO. "I'm pleased we can support policyholders with innovative insurance products as well as financially and have done so more consistently and effectively than others in the industry."

About MagMutual
For more than four decades, MagMutual has been a leading provider of medical professional liability insurance. Today, we're the largest mutual insurer of physicians and the second largest mutual medical professional liability provider in the U.S. We deliver comprehensive coverage for the practice, business and regulation of medicine to more than 40,000 healthcare providers and organizations nationwide. Our focus on innovation allows us to provide customized advice, exceptional claims support and consistent financial benefits that result in improved outcomes and stronger PolicyOwners.*

*Market position based on S&P Global Market Intelligence 2022 year-end financial filings. Dividends and Owners Circle allocations are declared at the discretion of the MagMutual Board of Directors and are subject to eligibility requirements.

Media Contact

Kristen Guilfoil, MagMutual, 404-842-3460, [email protected], www.magmutual.com

Twitter

SOURCE MagMutual


These press releases may also interest you

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)



News published on and distributed by: